<p>This study of three metastatic melanoma patients utilized exome sequencing and RNA sequencing to help identify putative neoantigen peptides that could be further validated by standard immunological assays before design of a personalized vaccine. For each set of neoantigens identified and verified by standard assays, we designed GMP peptides that correspond to the top neoantigens, then used these to condition dendritic cell isolates from each patient. The conditioned dendritic cells were used as the vaccine in three rounds of vaccination, followed by monitoring for T cell memory response to each of the neoantigens.</p>

Antigen Discovery in Melanoma

Melanoma-Specific Antigens study with RNA-Seq, WXS data on dbGaP (5 participants)

Antigen Discovery in Melanoma

Description

Applying For Access

Summary